【臨床試驗】《Massive Bio》與《Mika Health》合作為癌症患者提供臨床試驗配對

 【臨床試驗】《Massive Bio》與《Mika Health》合作為癌症患者提供臨床試驗配對

 文章出處  

Businesswire 

 

 原文標題  

Massive Bio and Mika Health Combine AI and Next-Generation Sequencing Biomarker Testing to Empower Cancer Patients On Treatment and Those Searching for and Participating in Clinical Trials in the United States and Europe 

 

 Twitter  

https://x.com/aimedadviser/status/1797615289838039268 

 

 文章序號  

5711 

 

智醫科學－AI醫療技術、應用與市場動態

Copyright ©2024 智醫科學 MEDai.tw All rights reserved.

The content of this site is intended for healthcare and medical professionals.